December 11, 2006 (Orlando) — Clinicians have a new biological prognostic indicator that is more specific than the classic risk factors of older age and risk of thrombosis. Researchers ...
QIAGEN 's QGEN ipsogen JAK2 RGQ PCR Kit (ipsogen JAK2 assay) received FDA approval for additional use in the diagnosis of all myeloproliferative neoplasms (MPNs). In this cancer group, blood cells in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results